This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jones, E. L. Articles by Dewhirst, M. W. Search for Related Content PubMed PubMed Citation Articles by Jones, E. L. Articles by Dewhirst, M. W. Social Bookmarking                            What's this?

Randomized Trial of Hyperthermia and Radiation for Superficial Tumors

From the Departments of Radiation Oncology, and Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC

Address reprint requests to Ellen L. Jones, MD, PhD, Radiation Oncology, Duke University Medical Center, DUMC Box 3085, Durham, NC 27710; e-mail: Jones{at}radonc.duke.edu

PURPOSE: Randomized clinical trials have demonstrated hyperthermia (HT) enhances radiation response. These trials, however, generally lacked rigorous thermal dose prescription and administration. We report the final results of a prospective randomized trial of superficial tumors ( 3 cm depth) comparing radiotherapy versus HT combined with radiotherapy, using the parameter describing the number of cumulative equivalent minutes at 43°C exceeded by 90% of monitored points within the tumor (CEM 43°C T₉₀) as a measure of thermal dose.

METHODS: This trial was designed to test whether a thermal dose of more than 10 CEM 43°C T₉₀ results in improved complete response and duration of local control compared with a thermal dose of 1 CEM 43°C T₉₀. Patients received a test dose of HT 1 CEM 43°C T₉₀ and tumors deemed heatable were randomly assigned to additional HT versus no additional HT. HT was given using microwave spiral strip applicators operating at 433 MHz.

RESULTS: One hundred twenty-two patients were enrolled; 109 (89%) were deemed heatable and were randomly assigned. The complete response rate was 66.1% in the HT arm and 42.3% in the no-HT arm. The odds ratio for complete response was 2.7 (95% CI, 1.2 to 5.8; P = .02). Previously irradiated patients had the greatest incremental gain in complete response: 23.5% in the no-HT arm versus 68.2% in the HT arm. No overall survival benefit was seen.

CONCLUSION: Adjuvant hyperthermia with a thermal dose more than 10 CEM 43°C T₉₀ confers a significant local control benefit in patients with superficial tumors receiving radiation therapy.

Supported by grant No. P01 CA42745 from the National Cancer Institute.

Authors' disclosures of potential conflicts of interest are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G. Galiana, R. T. Branca, E. R. Jenista, and W. S. Warren Accurate Temperature Imaging Based on Intermolecular Coherences in Magnetic Resonance Science, October 17, 2008; 322(5900): 421 - 424. [Abstract] [Full Text] [PDF]

				J. R. Ostberg, B. E. Dayanc, M. Yuan, E. Oflazoglu, and E. A. Repasky Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells J. Leukoc. Biol., November 1, 2007; 82(5): 1322 - 1331. [Abstract] [Full Text] [PDF]

				J. R. MacFall and B. J. Soher From the RSNA Refresher Courses: MR Imaging in Hyperthermia RadioGraphics, November 1, 2007; 27(6): 1809 - 1818. [Abstract] [Full Text] [PDF]

				K. R. Sekhar, V. N. Sonar, V. Muthusamy, S. Sasi, A. Laszlo, J. Sawani, N. Horikoshi, R. Higashikubo, R. G. Bristow, M. J. Borrelli, et al. Novel Chemical Enhancers of Heat Shock Increase Thermal Radiosensitization through a Mitotic Catastrophe Pathway Cancer Res., January 15, 2007; 67(2): 695 - 701. [Abstract] [Full Text] [PDF]

				D. E. Thrall, M. W. Dewhirst, E. L. Jones, Z. Vujaskovic, D. Yu, and O. I. Craciunescu A Clinically Proven, Prospective, Thermal Dose Descriptor Exists Clin. Cancer Res., March 15, 2006; 12(6): 1944 - 1945. [Full Text] [PDF]

				D. E. Thrall, S. M. LaRue, D. Yu, T. Samulski, L. Sanders, B. Case, G. Rosner, C. Azuma, J. Poulson, A. F. Pruitt, et al. Thermal Dose Is Related to Duration of Local Control in Canine Sarcomas Treated with Thermoradiotherapy Clin. Cancer Res., July 15, 2005; 11(14): 5206 - 5214. [Abstract] [Full Text] [PDF]